
Efficacy of NEPA (netupitant/palonosetron) across multiple cycles of chemotherapy in breast cancer patients: A subanalysis from two phase III trials
Keywords: NEPA; CINV; Breast cancer; Antiemetic; Netupitant; Palonosetron;